An Update on Autoinflammatory Diseases: Inflammasomopathies

Overview

Journal Curr Rheumatol Rep

Publisher Current Science

Specialty Rheumatology

Date 2018 May 31

PMID 29846819

Citations 34

Authors

Cassandra R Harapas

Annemarie Steiner

Sophia Davidson

Seth L Masters

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Autoinflammatory diseases are driven by abnormal innate immune activation. In the case of inflammasomopathies, these are all attributable to activation of an inflammasome complex, nucleated by an innate immune sensor such as NLRP3. This review will focus on recent advances that have helped to elucidate the role of three other sensors (NLRP1, NLRC4 and pyrin) which can also cause inflammasomopathies.

Recent Findings: Mutations in pyrin (S242R or E244K) destroy an inhibitory 14-3-3 binding site and result in the newly characterised disease pyrin-associated autoinflammation with neutrophilic dermatosis (PAAND). Moreover, a separate autoinflammatory disease driven by mevalonate kinase deficiency leads to defective RhoGTPase prenylation and subsequent loss of pyrin S242R phosphorylation, suggesting a shared mechanism of disease. Other inflammasomes such as NLRP1 and NLRC4 have had novel mutations described recently, which inform about the specific domains required for activation and autoinhibition. This review covers recent advances in the study of inflammasomopathies, focussing on gene discoveries that elucidate new pathogenic mechanisms.

Citing Articles

Development of human innate immune responses in a humanized mouse model expressing four human myelopoiesis transgenes.

Stocks H, De Leeuw E, Lambrecht B, Vandekerckhove L, van Loo G, Wullaert A Front Immunol. 2024; 15:1419117.

PMID: 39399507 PMC: 11466769. DOI: 10.3389/fimmu.2024.1419117.

Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry.

Vyzhga Y, Frenkel J, Insalaco A, Anton J, Kone-Paut I, Legger G J Clin Immunol. 2024; 44(5):119.

PMID: 38758228 DOI: 10.1007/s10875-024-01719-4.

Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA).

Cetin Gedik K, Arici Z, Kul Cinar O, Garcia-Bournissen F, Romano M, Demirkaya E Paediatr Drugs. 2024; 26(2):113-126.

PMID: 38376736 DOI: 10.1007/s40272-023-00615-5.

Hemophagocytic lymphohistiocytosis-like hyperinflammation due to a de novo mutation in DPP9.

Wolf C, Fischer H, Kuhl J, Koss S, Abou Jamra R, Starke S J Allergy Clin Immunol. 2023; 152(5):1336-1344.e5.

PMID: 37544411 PMC: 7615848. DOI: 10.1016/j.jaci.2023.07.013.

A human-specific motif facilitates CARD8 inflammasome activation after HIV-1 infection.

Kulsuptrakul J, Turcotte E, Emerman M, Mitchell P Elife. 2023; 12.

PMID: 37417868 PMC: 10359095. DOI: 10.7554/eLife.84108.

References

Canna S, de Jesus A, Gouni S, Brooks S, Marrero B, Liu Y . An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014; 46(10):1140-6. PMC: 4177369. DOI: 10.1038/ng.3089. View

Lidar M, Scherrmann J, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R . Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum. 2004; 33(4):273-82. DOI: 10.1053/s0049-0172(03)00137-9. View

Van Gorp H, Saavedra P, De Vasconcelos N, Van Opdenbosch N, Vande Walle L, Matusiak M . Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation. Proc Natl Acad Sci U S A. 2016; 113(50):14384-14389. PMC: 5167202. DOI: 10.1073/pnas.1613156113. View

Kile B, Panopoulos A, Stirzaker R, Hacking D, Tahtamouni L, Willson T . Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrombocytopenia. Blood. 2007; 110(7):2371-80. PMC: 1988957. DOI: 10.1182/blood-2006-10-055087. View

Alghamdi M . Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017; 36(8):1707-1713. DOI: 10.1007/s10067-017-3715-5. View

Ratner D, Orning M, Proulx M, Wang D, Gavrilin M, Wewers M . The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation. PLoS Pathog. 2016; 12(12):e1006035. PMC: 5135138. DOI: 10.1371/journal.ppat.1006035. View

Liu X, Zhang Z, Ruan J, Pan Y, Magupalli V, Wu H . Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016; 535(7610):153-8. PMC: 5539988. DOI: 10.1038/nature18629. View

Gao W, Yang J, Liu W, Wang Y, Shao F . Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation. Proc Natl Acad Sci U S A. 2016; 113(33):E4857-66. PMC: 4995971. DOI: 10.1073/pnas.1601700113. View

Adams S, Miller G, Jesson M, Watanabe T, Jones B, Wallner B . PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res. 2004; 64(15):5471-80. DOI: 10.1158/0008-5472.CAN-04-0447. View

10.

Sellin M, Muller A, Felmy B, Dolowschiak T, Diard M, Tardivel A . Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe. 2014; 16(2):237-248. DOI: 10.1016/j.chom.2014.07.001. View

11.

Kim M, Chae J, Park Y, De Nardo D, Stirzaker R, Ko H . Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β. J Exp Med. 2015; 212(6):927-38. PMC: 4451132. DOI: 10.1084/jem.20142384. View

12.

GOLDFINGER S . Colchicine for familial Mediterranean fever. N Engl J Med. 1972; 287(25):1302. DOI: 10.1056/NEJM197212212872514. View

13.

Rauch I, Deets K, Ji D, von Moltke J, Tenthorey J, Lee A . NAIP-NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL-18 Release via Activation of Caspase-1 and -8. Immunity. 2017; 46(4):649-659. PMC: 5476318. DOI: 10.1016/j.immuni.2017.03.016. View

14.

Moghaddas F, Llamas R, De Nardo D, Martinez-Banaclocha H, Martinez-Garcia J, Mesa-Del-Castillo P . A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever. Ann Rheum Dis. 2017; 76(12):2085-2094. PMC: 5687562. DOI: 10.1136/annrheumdis-2017-211473. View

15.

Broderick L, De Nardo D, Franklin B, Hoffman H, Latz E . The inflammasomes and autoinflammatory syndromes. Annu Rev Pathol. 2014; 10:395-424. DOI: 10.1146/annurev-pathol-012414-040431. View

16.

Masters S, Lagou V, Jeru I, Baker P, Van Eyck L, Parry D . Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Sci Transl Med. 2016; 8(332):332ra45. DOI: 10.1126/scitranslmed.aaf1471. View

17.

Jones J, Dangl J . The plant immune system. Nature. 2006; 444(7117):323-9. DOI: 10.1038/nature05286. View

18.

Zhang S . Natural history of mevalonate kinase deficiency: a literature review. Pediatr Rheumatol Online J. 2016; 14(1):30. PMC: 4855321. DOI: 10.1186/s12969-016-0091-7. View

19.

Hoffman H, Mueller J, Broide D, Wanderer A, Kolodner R . Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001; 29(3):301-5. PMC: 4322000. DOI: 10.1038/ng756. View

20.

Xu H, Yang J, Gao W, Li L, Li P, Zhang L . Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature. 2014; 513(7517):237-41. DOI: 10.1038/nature13449. View